作者
Hongliu Zhu,Jianqiu Yang,毛秋霞,Xuling Wu,Zixi Wang,Lechi Feng,Yihong Gao
摘要
Background Androgenetic alopecia (AGA) is a common hair loss disorder with limited effective therapeutic options. Pinus massoniana needles extract (PMNE) has shown potential in promoting hair regrowth; however, the molecular basis underlying its effects remains incompletely understood. Purpose This study employed an integrated multiomics strategy to evaluate the therapeutic effects of PMNE in AGA and to identify molecular pathways potentially associated with its activity. Materials and Methods The chemical composition of PMNE was characterized using UPLC‐Q‐Orbitrap HRMS. A dihydrotestosterone (DHT)‐induced mouse model of AGA was established to assess the efficacy of topical PMNE through photographic evaluation, histological examination, and biochemical analyses. Transcriptomics, metabolomics, and network pharmacology analyses were integrated to prioritize candidate pathways, followed by molecular docking and in vivo validation using RT‐qPCR analyses. Results Seventy‐seven compounds, primarily flavonoids, were annotated in PMNE. Topical PMNE treatment significantly promoted hair regrowth and improved follicular cycling in AGA mice, accompanied by reduced oxidative stress, as indicated by decreased ROS and MDA levels and increased SOD activity ( p < 0.05). Integrated transcriptomic and metabolomic analyses highlighted immune‐ and metabolism‐related pathways, including those associated with Th17 cell differentiation and steroid hormone biosynthesis. In addition, PMNE treatment modulated the expression of proliferation‐ and apoptosis‐related markers, including KRT14 , IGF-1 , TGF-β1 , BCL-2 , Bax , and Caspase-3 , in mouse skin tissues ( p < 0.05). Molecular docking analysis suggested potential interactions between catechin and several candidate targets, including MAPK1, CYP19A1, and TNF. Conclusions PMNE exerts beneficial effects on AGA in vivo, potentially through the attenuation of oxidative stress and the modulation of immune‐, metabolic‐, and apoptosis‐related processes. These findings provide multiomics‐guided insights into the molecular pathways associated with PMNE treatment and support its further investigation as a potential therapeutic agent for AGA.